Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04958577
Other study ID # AFYA
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date August 3, 2021
Est. completion date June 1, 2022

Study information

Verified date May 2022
Source Ada Health GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will evaluate the accuracy of the condition suggestions and urgency advice of the Swahili language Ada symptom assessment application (SAA), when symptoms are input by a lay-person user and a medical professional; these SAA results will then be compared to the condition suggestions and urgency advice of different tiers of doctors and a "gold standard" created by a panel.


Description:

There will be two different wings of this study: (1) where a lay-person inputs their symptoms into the Swahili language Ada symptom assessment application (SAA); (2) where the usual care doctor asks a lay-person (the patient) the same questions from the SAA and determines their own condition suggestions based off this questioning and the SAA's condition suggestions. In both wings, the patient will be seeing their usual care doctor for a diagnosis and then a study-provided physician for a diagnosis. Separately, the doctors will list a ranking of other considered condition suggestions (diagnoses) and urgency advice, which will not be shared with the patient. These condition suggestions and urgency advice will be compared to a "gold standard", which will be determined by a high level panel for each patient's case, based on the doctor notes and physical examination results of each patient's visit.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 109
Est. completion date June 1, 2022
Est. primary completion date December 17, 2021
Accepts healthy volunteers No
Gender All
Age group 2 Months and older
Eligibility Inclusion Criteria: - All patients who enter the clinic and that are willing/able to provide consent will be included, except those who fall under certain conditions listed below Exclusion Criteria: - Patients with severe injury/illness requiring immediate treatment - Patients with traumatic injury (many of these patients require minimal anamnesis, and it is not rational to include them in a pilot study) - Patients incapable of completing a health assessment (e.g. due to illiteracy, mental impairment or inebriation or other incapacity).

Study Design


Intervention

Device:
Ada Waiting Room App (WRA) and Ada Diagnostic Support Application (HDA)
This device is a medical device but will be used only observationally--this device takes a patient's symptoms into account by asking questions and gives a ranked list of likely conditions that the patient might have based on the answers to these questions. The assessment report also includes urgency advice levels, that is, which care the patient should proceed to based on the condition suggestions. The WRA is used by the patient directly and the HDA is used by the doctor to ask the questions to the patient.

Locations

Country Name City State
Tanzania Mbagala Rangi Tatu Hospital Dar Es Salaam

Sponsors (2)

Lead Sponsor Collaborator
Ada Health GmbH Muhimbili University of Health and Allied Sciences

Country where clinical trial is conducted

Tanzania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy and Comprehensiveness measures of Ada WRA and HDA The condition-suggestion accuracy and comprehensiveness of the SAA, evaluated against the gold-standard differential diagnosis determined by the review panel, reported in the context of the accuracy of the usual care health practitioner. through study completion, an average of 4 months
Secondary Comparison of usual care doctor condition suggestions In Wing B only, while using the Ada HDA, the difference between the usual care doctor's condition suggestion accuracy and urgency advice will be compared between (1) the study arm where they determine a ranked list of condition suggestions before seeing Ada's list and then will choose a new ranked list based on viewing Ada's list, and (2) the study arm where after using the HDA, the doctor will see Ada's ranked list of condition suggestions and then choose to use Ada's full list or add some condition suggestions of their own. The accuracy of these will then also be compared to the study-provided physician and the gold standard panel. through study completion, an average of 4 months
Secondary Urgency advice accuracy The urgency advice accuracy of the SAA, evaluated against the gold-standard triage levels determined by the review panel, reported in the context of the accuracy of the usual care health practitioner. through study completion, an average of 4 months
Secondary Questionnaire data insights Qualitative data on the usability, usefulness and acceptance of the SAA through study completion, an average of 4 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04556565 - MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain
Recruiting NCT05336955 - Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities N/A
Completed NCT02657954 - ASPIRE Cognitive Enhancement Study N/A
Recruiting NCT04245423 - The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions N/A